Omega Hospitals Acquires Cytecare Bengaluru to Expand Cancer Care Network

The hospital, established in 2016 on the international airport road, has built its presence through clinical services, patient-focused care, and research.

Omega Hospitals, backed by Morgan Stanley Private Equity, has acquired Cytecare Hospitals, a 150-bed NABH-accredited oncology centre in North Bengaluru, marking its entry into the micro-market. 

The hospital, established in 2016 on the international airport road, has built its presence through clinical services, patient-focused care, and research.

Commenting on the acquisition, Dr Mohana Vamsy, Managing Director of Omega Hospitals, said, “This acquisition is a significant milestone for Omega, providing an entry in an important geography we want to focus on outside our core geographies of AP & Telangana. Over the last 2 years, we have been working on creating pan-India centres of excellence, and our recent foray in Jabalpur, Surat, Vijaywada, Tirupati, and now Bangalore is part of the same expansion strategy. We hope to deliver on our commitment to provide advanced and high-quality care for cancer patients.”

Prateek Bhurat, Executive Director at Morgan Stanley Private Equity, added, “We have been in touch with Dr Ferzaan and team for the past year and are very pleased that the deal has concluded. We recognise that Cytecare is strategically located, has good clinical talent, and has tremendous potential for future growth. This unit will be developed as Omega’s centre of excellence for quaternary cancer care with investment earmarked for top clinical talent and high-end medical equipment.”

Morgan Stanley Private Equity had invested approximately ₹500 crore in Omega Hospitals in June 2024. The acquisition is part of Omega’s ongoing pan-India expansion in cancer care, with recent entries into Jabalpur, Tirupati, Surat, Vijayawada, and Yamuna Nagar. 

Omega currently operates 14 hospitals with around 2,000 beds across five states and has strengthened leadership with the appointment of Dr Vijay Vemuri, previously associated with AOI, as Executive Director.

Spark Capital Investment Banking advised Cytecare Hospitals on the transaction.

Stay tuned for more such updates on Digital Health News